Status:
COMPLETED
Otoacoustic Emission Suppression Study
Lead Sponsor:
Intelligent Hearing Systems
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Vanderbilt University
Conditions:
Neonatal Hearing Loss
Eligibility:
All Genders
Brief Summary
The focus of this project is on a physiologic auditory response called the Medial Olivocochlear Reflex (MOCR) that assesses peripheral neural function. While neural hearing loss is a significant audit...
Detailed Description
The objective of this study is to develop an optimized hearing testing method using otoacoustic emissions, that can be used to efficiently assess peripheral neural function (including retrocochlear di...
Eligibility Criteria
Inclusion
- Normal middle-ear function
- Present TEOAEs.
Exclusion
- Atresia or other external ear abnormalities not allowing recording of OAEs
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 12 2023
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT04749524
Start Date
April 1 2020
End Date
July 12 2023
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical School
Nashville, Tennessee, United States, 37232